ECAU
CELG

Everett Capital Advisors (UK)’s Celgene Corp CELG Stock Holding History

Everett Capital Advisors (UK)’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-118,750
Closed -$11.8M – 31
2019
Q3 		$11.8M Buy
+118,750
New +$11.3M 1.91% 13
2019
Q2 		– Sell
-161,000
Closed -$15.2M – 46
2019
Q1 		$15.2M Buy
+161,000
New +$14.1M 1.51% 17

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Everett Capital Advisors (UK)'s CELG Position: Q4 2019 in Review

Everett Capital Advisors (UK) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 118,750 shares — an estimated $11.8M sold.

Everett Capital Advisors (UK) first reported a position in CELG in Q1 2019 and held it in 2 quarters. The position peaked at $15.2M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Everett Capital Advisors (UK) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Everett Capital Advisors (UK) sold 118,750 Celgene Corp shares in Q4 2019, an estimated $11.8M.
  • Everett Capital Advisors (UK) first reported a position in Celgene Corp in Q1 2019 and held it in 2 quarters.
  • Everett Capital Advisors (UK)'s Celgene Corp position peaked at $15.2M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Everett Capital Advisors (UK)'s 13F filing for Q4 2019, filed 15 Jan 2020.